M&T Bank Corp Decreases Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

M&T Bank Corp lessened its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 30.9% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,098 shares of the medical instruments supplier’s stock after selling 1,383 shares during the period. M&T Bank Corp’s holdings in ICU Medical were worth $481,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Barclays PLC increased its holdings in ICU Medical by 15.6% during the third quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier’s stock worth $10,790,000 after buying an additional 8,010 shares during the last quarter. LMR Partners LLP purchased a new stake in ICU Medical during the third quarter worth about $3,884,000. Principal Financial Group Inc. increased its holdings in ICU Medical by 24.6% during the third quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock worth $23,130,000 after buying an additional 25,031 shares during the last quarter. MetLife Investment Management LLC increased its holdings in ICU Medical by 129.1% during the third quarter. MetLife Investment Management LLC now owns 12,389 shares of the medical instruments supplier’s stock worth $2,258,000 after buying an additional 6,981 shares during the last quarter. Finally, Jennison Associates LLC purchased a new stake in ICU Medical during the fourth quarter worth about $556,000. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Price Performance

Shares of NASDAQ:ICUI opened at $140.19 on Friday. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $3.44 billion, a PE ratio of -30.68 and a beta of 0.73. ICU Medical, Inc. has a twelve month low of $93.36 and a twelve month high of $196.26. The company has a 50-day moving average price of $157.96 and a two-hundred day moving average price of $165.25.

Insiders Place Their Bets

In other news, CEO Vivek Jain sold 1,373 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 6.70% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Raymond James set a $97.00 price objective on shares of ICU Medical in a report on Wednesday. StockNews.com lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a research report on Monday. Finally, Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price for the company in a research report on Wednesday, December 11th. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, ICU Medical presently has an average rating of “Moderate Buy” and a consensus target price of $168.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.